| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 554,9 k € | +10.6% | 501,7 k € | +9.8% | 456,9 k € | -31.0% | 661,7 k € | +133.6% | 283,2 k € | -12.1% | 322,3 k € | -2.6% | 331,0 k € | +3.8% | 318,9 k € | -12.4% | 363,8 k € | +19.7% | 303,9 k € | +11.3% | 273,1 k € | +12.2% | 243,4 k € | +22.9% | 198,1 k € | -38.2% | 320,3 k € | +66.0% | 192,9 k € | +66.5% | 115,9 k € | +623.2% | -22,1 k € | -220.7% | 18,4 k € | -76.5% | 78,1 k € | |
| EBITDA | 553,8 k € | +10.6% | 500,6 k € | +9.9% | 455,5 k € | -31.1% | 660,7 k € | +134.2% | 282,1 k € | -12.5% | 322,3 k € | -2.1% | 329,2 k € | +3.7% | 317,4 k € | -12.4% | 362,4 k € | +19.4% | 303,4 k € | +14.1% | 265,9 k € | +9.8% | 242,3 k € | -12.2% | 276,1 k € | -13.6% | 319,5 k € | +182.6% | 113,1 k € | -0.9% | 114,1 k € | +591.5% | -23,2 k € | -235.4% | 17,1 k € | -77.6% | 76,7 k € | |
| Operating profit | 545,7 k € | +10.8% | 492,5 k € | +10.0% | 447,6 k € | -31.5% | 653,1 k € | +137.9% | 274,5 k € | -14.8% | 322,1 k € | -0.5% | 323,8 k € | +3.8% | 312,0 k € | -12.6% | 357,1 k € | +20.0% | 297,7 k € | +14.6% | 259,8 k € | +10.1% | 236,0 k € | -12.7% | 270,2 k € | -13.8% | 313,4 k € | +194.2% | 106,5 k € | -1.0% | 107,6 k € | +549.5% | -23,9 k € | -243.7% | 16,7 k € | -78.1% | 75,9 k € | |
| Profit/loss | 376,0 k € | +4.3% | 360,7 k € | +5.6% | 341,6 k € | -31.7% | 500,1 k € | +151.3% | 199,0 k € | -9.7% | 220,5 k € | -1.4% | 223,7 k € | +13.6% | 197,0 k € | -21.2% | 249,9 k € | +42.9% | 175,0 k € | +8.1% | 161,8 k € | -3.0% | 166,9 k € | -9.8% | 185,0 k € | -10.2% | 205,9 k € | +193.0% | 70,3 k € | -11.2% | 79,1 k € | +420.2% | -24,7 k € | -284.4% | 13,4 k € | -74.7% | 53,0 k € | |
| Equity | 983,4 k € | +18.2% | 832,1 k € | -2.4% | 852,4 k € | -0.3% | 854,7 k € | -33.3% | 1,3 M € | +3.0% | 1,2 M € | +21.5% | 1,0 M € | +3.5% | 989,0 k € | +24.9% | 792,0 k € | -0.0% | 792,1 k € | +28.4% | 617,1 k € | +35.5% | 455,3 k € | +11.2% | 409,5 k € | +82.4% | 224,4 k € | +1113.6% | 18,5 k € | -86.1% | 133,2 k € | +146.4% | 54,1 k € | -31.4% | 78,8 k € | +20.5% | 65,4 k € | |
| Total assets | 1,1 M € | +1.1% | 1,1 M € | -13.3% | 1,2 M € | -11.3% | 1,4 M € | +5.4% | 1,3 M € | -0.2% | 1,3 M € | +21.4% | 1,1 M € | +2.0% | 1,1 M € | -3.1% | 1,1 M € | +28.3% | 852,9 k € | +26.0% | 677,2 k € | +15.7% | 585,2 k € | +33.8% | 437,2 k € | +30.9% | 334,0 k € | +2.0% | 327,3 k € | +65.4% | 197,9 k € | +121.6% | 89,3 k € | -22.0% | 114,4 k € | -8.2% | 124,7 k € | |
| Cash | 854,2 k € | +3.3% | 826,5 k € | -15.8% | 982,0 k € | -3.3% | 1,0 M € | +21.4% | 836,3 k € | -6.4% | 893,9 k € | +45.0% | 616,5 k € | +15.8% | 532,3 k € | -5.2% | 561,6 k € | +77.5% | 316,4 k € | -5.3% | 334,0 k € | +27.5% | 262,0 k € | +20.3% | 217,9 k € | +20.1% | 181,4 k € | -35.3% | 280,1 k € | +60.8% | 174,2 k € | +98.0% | 88,0 k € | -13.5% | 101,7 k € | -7.6% | 110,0 k € | |
| Debts | 81,8 k € | -64.0% | 226,9 k € | -38.4% | 368,5 k € | -29.4% | 521,9 k € | +2134.6% | 23,4 k € | -64.4% | 65,7 k € | +20.0% | 54,7 k € | -20.0% | 68,4 k € | -77.1% | 299,3 k € | +420.3% | 57,5 k € | -0.2% | 57,6 k € | -54.8% | 127,6 k € | +398.2% | 25,6 k € | -12.5% | 29,2 k € | -87.1% | 227,2 k € | +265.7% | 62,1 k € | +88.1% | 33,0 k € | -2.7% | 33,9 k € | -42.7% | 59,2 k € | |
Private limited company · Ranst · incorporated on 12/12/2006
Private limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DOKTER JACOBS NADIA is a Private limited company incorporated in 2006. Its main activity is: Other human health activities. Its registered office is in Ranst.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette